<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestionSet xmlns="http://soap.sforce.com/2006/04/metadata">
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q2</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q3</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q4</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q5</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q6</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q7</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q8</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q8_R1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q9</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q10</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q11</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q12</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q13</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q14</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q20_R1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q16</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q17</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q18</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q19</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q20</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q21</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q22</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q23</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Lanadelumab_Renewal_RenewalCriteria_Q24</assessmentQuestionDeveloperNames>
    <developerName>Lanadelumab_Renewal_RenewalCriteria_QS</developerName>
    <name>Lanadelumab_Renewal_RenewalCriteria_QS</name>
</AssessmentQuestionSet>
